NCT06827704 Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
| NCT ID | NCT06827704 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rush University Medical Center |
| Condition | Metabolic Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2025-05-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.
Eligibility Criteria
Inclusion Criteria: * Self-identified first-generation SAI woman aged 40-65 years without breast cancer diagnosis (permanent residency in US or are in the process of obtaining permanent residency) * Insufficiently active (self-reported \<150 minutes/week of moderate-intensity or \<75 minutes/week of vigorous-intensity PA in the past month) * Conversant in Hindi * Owns a smartphone for Fitbit application * Has a computer or mobile device with Internet access * Willing to participate in recorded Virtual intervention sessions * Medical clearance if has Type 1 diabetes, or Type 2 diabetes with an A1C ≥ 9.0%, or have an A1C of ≥ 6.5% without a prior diabetes diagnosis * Has no disabilities preventing regular PA determined by Physical Activity Readiness Questionnaire (PAR-Q \& You) Exclusion Criteria: * Major signs/symptoms of pulmonary or CVD, unstable cardiac or pulmonary disease in the past month, or other conditions interfering with walking (per PAR-Q \& You) * Systolic BP ≥160 and/or diastolic BP ≥100
Contact & Investigator
Manju Daniel, PhD
PRINCIPAL INVESTIGATOR
Rush University College of Nursing
Frequently Asked Questions
Who can join the NCT06827704 clinical trial?
This trial is open to female participants only, aged 40 Years or older, up to 65 Years, studying Metabolic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06827704 currently recruiting?
Yes, NCT06827704 is actively recruiting participants. Contact the research team at manju_n_daniel@rush.edu for enrollment information.
Where is the NCT06827704 trial being conducted?
This trial is being conducted at Chicago, United States, Sugar Grove, United States.
Who is sponsoring the NCT06827704 clinical trial?
NCT06827704 is sponsored by Rush University Medical Center. The principal investigator is Manju Daniel, PhD at Rush University College of Nursing. The trial plans to enroll 96 participants.